The Future of Mental Health

Boston, MA US
September 16, 2022 to September 17, 2022

Over the last few years, the field of mental health has garnered the most investments relative to other clinical areas. This program brings together clinicians, scientists, entrepreneurs, and investors to understand what mental health care can and should look like in the next 2 decades. By all accounts, current systems of care do not serve patients and their families well: care is hard to access, inefficient and costly, and sometimes unable to restore function and quality of life. At the same time, from neuroimaging to artificial intelligence to mobile apps, we are bombarded with excitement about the future might bring. How do we get past the hype to envision better care? A key first step is understanding what the future could look like, and what would need to happen to make it a reality.

In-Person Pricing: 

Physicians, Psychologists, and Doctoral-level Professionals: $795.00
Other Professionals: $695.00
Students: Free
Residents & Fellows: Free

*NEW* Virtual Pricing

Physicians, Psychologists, and Doctoral-level Professionals: $695.00
Other Professionals: $595.00
Students: Free
Residents & Fellows: Free

Target Audience

This two-day conference is intended for clinicians, scientists, entrepreneurs, students, payers and investors with an interest in the future of mental health care

Learning Objectives

  • Identify emerging technologies that may yield more effective and efficient diagnosis and treatment in mental health.
  • Identify the challenges in developing and deploying these technologies in mental health.
  • Describe ways in which key stakeholders can work together to overcome these challenges, by considering examples of these collaborations.
Course summary
Available credit: 
  • 0.00 Participation

    This course allows other providers to claim a Participation Certificate upon successful completion of this course.

    Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.

Registration opens: 
04/30/2022
Course closes: 
10/31/2022
Event starts: 
09/16/2022 - 7:30am EDT
Event ends: 
09/17/2022 - 3:05pm EDT
Cost:
$795.00
Rating: 
0

Future of Mental Health Conference
September 16 - 17, 2022
Westin Copley – Boston, MA

Day 1 – September 16, 2022     

7:30 AM                                     Continental Breakfast and Registration

8:30 AM -8:35 AM                     Welcome & Keynote Introduction
David Mou, MD; Roy Perlis, MD

8:35 AM - 9:00 AM                    Keynote Speaker: Thomas R. Insel, MD
                                                    Healing: Our Path from Mental Illness to Mental Health

9:00 AM - 10:30 AM                  The Future of CNS Drug Development Panel Discussion
Moderator: Roy Perlis, MD
Panelists: Steve M. Paul, MD, Amit Etkin, MD, PhD, Errol DeSouza, PhD,  John Dunlop, PhD

10:30 AM - 10:45 AM                 Coffee Break

10:45 AM 12:15 PM                   The Promise and Perils of Psychedelics Panel Discussion
Moderator: Jerrold Rosenbaum, MD
Panelists: George J. Goldsmith, Mark Rus, Cristina Cusin, MD, Aidan Hampson, PhD

12:15 PM - 1:30 PM                   Lunch Break (On you own)

1:30 - 3:00 PM                           How Telehealth is Transforming Mental Health Delivery Panel Discussion
Moderator: David Mou, MD
Panelists: Stephen Smith, Andrew Welchman, PhD, Anthony Sossong, MD, Seth Feuerstein, MD, JD

3:00 PM - 3:15 PM                    Coffee Break

3:15 PM - 4:45 PM                    The Future of Digital Therapeutics Panel Discussion
Moderator: Sabine Wilhelm, PhD
Panelists:
Corey McCann, MD, PhD, Eddie Martucci, PhD, Peter Hames, Emily Lattie, PhD, Faith Gunning, PhD

4:45 PM                                     Adjourn

                       

Day 2 – September 17, 2022     

7:30 AM                                     Continental Breakfast and Registration

8:30 AM - 8:35 AM                    Introduction
David Mou, MD; Roy Perlis, MD

8:35 AM - 9:00 AM                    Keynote Speaker: Maurizio Fava, MD

9:00 AM - 10:30 AM                  Where is Mental Health Headed? Perspectives from Investors Panel Discussion
 Moderator: David Mou, MD
 Panelists: Roger Kitterman, MBA, Alexandra Cantley, Solome Tibebu

10:30 AM - 10:45 AM                Coffee Break

10:45 AM – 11:10 AM                Keynote Speaker: Jim Yong Kim, MD, PhD
Building the Movement for Mental Health Treatment Access:  Lessons from Four Decades of Global Health Activism

11:10 AM - 12:30 PM                 Rethinking Access and Quality in Behavioral Health: Perspectives from Payers Panel Discussion
Moderator:  John Herman, MD
Panelists: Neil Leibowitz, MD, JD, Doug Nemecek, MD, MBA, Giuseppe Raviola, MD, MPH

12:30 PM - 1:30 PM                  Lunch Break (On your own) 

1:30 PM - 3:00 PM                    Leveraging Data Science to Improve Mental Health
Moderator. Roy Perlis, MD
Panelists: Marzyeh Ghassemi, PhD, Zayed Yasin, MD, MBA, Carl D. Marci, MD, Andy Keller, PhD, Christopher Palmer, MD

3:00 PM                                    Closing Remarks

3:05 PM                                    Adjourn

 

 

 

 

The Westin Copley Place
10 Huntington Avenue
Boston, MA 02116
United States
+1 (617) 262-9600

Join us at the Westin Copley Place for The Future of Mental Health

 

We have arranged a special discounted rate for our valued attendees.
Please book by August 19, 2022 to enjoy this group rate.

 

Reserve your room now!

COURSE DIRECTORS

Roy H. Perlis, MD, MSc
Professor of Psychiatry, HMS
Director, Center for Experimental Drugs and Diagnostics, MGH

David Mou, MD, MBA
Director, MGH Psychiatry’s Innovation Council
Chief Executive Officer, Cerebral

SPEAKERS

Alexandra Cantley, PhD
Partner
Polaris Partners
Cristina Cusin, MD
Director, Ketamine Clinic and Associate Director, Depression Clinical and Research Program
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard Medical School
Dr. Errol B. De Souza
Executive Chairman
Bionomics Ltd.
John Dunlop, PhD
Head of Research and Development
Neumora Therapeutics
Amit Etkin
Founder and CEO
Alto Neuroscience
Seth D. Feuerstein, MD, JD
Faculty, Yale School of Medicine
Founder and CEO, Oui Therapeutics
Founder, Board Chair, Vytyl Health
Senior Advisor, Athyrium Capital
HQE, Department of Defense

Marzyeh Ghassemi, PhD
Herman L. F. von Helmholtz Career Development Professor, CIFAR Azrieli Global Scholar
Assistant Professor, Massachusetts Institute of Technology (MIT) in Electrical Engineering and Computer Science (EECS) and Institute for Medical Engineering & Science (IMES)
CIFAR AI Chair, Vector Institute

George J. Goldsmith
Chairman, CEO and Co-Founder, COMPASS Pathways PLC
Faith Gunning, Ph.D.
Associate Professor of Psychology in Psychiatry
Director of the Weill Cornell Institute of Geriatric Psychiatry
Vice Chair for Research
Department of Psychiatry
Peter Hames
Co-Founder and President
Big Health
Andy Keller, PhD
President and CEO
Linda Perryman Evans Presidential Chair
Meadows Mental Health Policy Institute
Roger Kitterman
Vice President
Mass General Brigham Ventures

Emily Lattie, PhD
Assistant Professor | Dept. of Medical Social Sciences
Associate Director of Training | Center for Behavioral Intervention Technologies (CBITs)
Northwestern University Feinberg School of Medicine

Neil Leibowitz, MD, JD
CMO
Beacon Health Options
Carl D. Marci, MD
Assistant Professor of Psychiatry, Harvard Medical School (part-time)
Staff Clinician, MGH Revere Mental Health Center (part-time)
Chief Psychiatrist and Managing Director, Mental Health and Neuroscience, OM1, Inc.
W. Eddie Martucci, PhD
CEO and Co-Founder, Akili
Corey M. McCann, MD, PhD
President and CEO, Pear Therapeutics, Inc
Doug Nemecek, MD, MBA
Chief Medical Officer
Evernorth Behavioral Health
Christopher M. Palmer, MD
Director, Dept. of Postgraduate and Continuing Education, McLean Hospital
Assistant Professor of Psychiatry, Harvard Medical School
Steven M. Paul, MD
CEO and Chairman
Karuna Therapeutics
Professor of Psychiatry and Neurology
Washington University School of Medicine
Guiseppe Raviola, MD, MPH
Massachusetts General Hospital
Department of Psychiatry
Associate Director, The Chester M. Pierce, MD Global Psychiatry Division
Assistant Professor of Psychiatry
Division of Child and Adolescent Psychiatry
Harvard Medical School
Department of Global Health and Social Medicine
Director, The Program in Global Mental Health and Social Change
Assistant Professor in Global Health and Social Medicine
Jerrold Rosenbaum, MD
Psychiatrist-in-Chief, Emeritus
Director, Center for the Neuroscience of Psychedelics
Massachusetts General Hospital
Stanley Cobb Professor of Psychiatry
Harvard Medical School
Mark Rus
Chief Executive Officer
Delix Therapeutics
Stephen Smith
Cofounder and CEO of NOCD

Anthony Sossong, MD
Chief Medical Director, Behavioral Health, Amwell

Andrew Welchman, PhD
Executive Vice President, Impact, ieso

Sabine Wilhelm, PhD
Chief of Psychology, Massachusetts General Hospital
Director, OCD Program, Massachusetts General Hospital
Chair, Digital Health Think Tank
Professor, Harvard Medical School

Zayed Yasin, MD, MBA
SVP, Clinical
Firsthand

Available Credit

  • 0.00 Participation

    This course allows other providers to claim a Participation Certificate upon successful completion of this course.

    Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.

Price

Cost:
$795.00
Please login or register to take this course.